Novartis AG
SWB:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
SWB:NOT
|
CH |
|
B
|
Bank of New York Mellon Corp
DUS:BN9
|
US |
|
Bank of China Ltd
F:W8VS
|
CN |
|
S
|
Sea Ltd
F:931
|
SG |
|
Uber Technologies Inc
BMV:UBER
|
US |
|
Terna Rete Elettrica Nazionale SpA
MIL:TRN
|
IT |
|
B
|
Bank of New York Mellon Corp
XMUN:BN9
|
US |
|
F
|
First Citizens BancShares Inc (Delaware)
F:FC6A
|
US |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for
NOT is 135.09 EUR with a low forecast of 99.79 EUR and a high forecast of 159.6 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
135.09
EUR
According to Wall Street analysts, the average 1-year price target for
NOT is 135.09 EUR with a low forecast of 99.79 EUR and a high forecast of 159.6 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.